Table 2: Prevalence of Posttransplant Metabolic Syndrome  (PTMS) and its components.

PTMS45–58%
Obesity21–43%
Hypertension62–69%
Hypertriglyceridemia66–85%
Low HDL-C48–52%
Posttransplant de novo fatty liver disease 18–40% (100% recurrence in patients transplanted for cryptogenic cirrhosis at 5 years)